신생아 패혈증에서의 항균제 치료

키워드

참고문헌 (36)

1. Stoll BJ, "Neurodevelopmental and growth impairment among extremely low birth weight infants with neonatal infection", JAMA, 292, pp.2357~2365 (2004)
2. Philip AGS, "Neonatal meningitis in the new millennium", Neoreviews, 4, pp.73~80 (2003)
3. Puopolo KM, "Epidemiology of neonatal early-onset sepsis", Neoreviews, 9, pp.571~579 (2008)
4. Stoll BJ, "Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants", N Engl J Med, 347, pp.240~247 (2002)
5. Stoll BJ, "Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network 2001-2003", Pediatr Infect Dis J, 24, pp.635~639 (2005)
6. Zaidi AK, "Pathogens associated with sepsis in newborns and young infants in developing countries", Pediatr Infect Dis J, 28, pp.10~18 (2009)
7. 박혜원, "단일 신생아중환자실에서 경험한 10년간의 신생아 패혈증의 원인균 및 항생제 감수성 변화", Neonatal medicine, 16(2), pp.172~181 (2009), 대한신생아학회
8. Stoll BJ, "Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network", Pediatrics, 110, pp.285~291 (2002)
9. Vergnano S, "Neonatal infections in England: the NeonIN serveillance network", Arch Dis Child Fetal Neonatal, 96, pp.9~14 (2011)
10. Makhoul IR, "Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey", Pediatrics, 109, pp.34~39 (2002)
11. Muller-Pebody B, "Empirical treatment of neonatal sepsis: are the current guidelines adequate?", Arch Dis Child Fetal Neonatal, 96, pp.4~8 (2011)
12. Puopolo KM, "Bacterial and Fungal Infection, In Manual of Neonatal Care. 6th ed", pp.274~308 (2008), Lippincott Williams & Wilkins
13. Kaiser JR, "Should antibiotics be discontinued at 48 hours for negative late-onset sepsis evaluations in the neonatal intensive care unit?", J Perinatol, 22, pp.445~447 (2002)
14. Rodwell RL, "Early diagnosis of neonatal sepsis using a hematologic scoring system", J Pediatr, 112, pp.761~767 (1998)
15. Kuppala VS, "Prolonged initial empirical antibiotic treatment is associated with adverse outcome in premature infants", J Pediatr, 159, pp.720~725 (2011)
16. Benjamin DK Jr, "Neonatal candidiasis: epidemiology, risk factors, and clinical judgment", Pediatrics, 126, pp.865~873 (2010)
17. 박상혁, "Clinical Relevance of Time-to-positivity in BACTEC9240 Blood Culture System", Annals of Laboratory Medicine, 30(3), pp.276~283 (2010), 대한진단검사의학회
18. Butler KM, "Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates", Pediatr Infect Dis J, 9, pp.51~56 (1990)
19. Kicklighter SD, "Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant", Pediatrics, 107, pp.293~298 (2001)
20. Kaufman D, "Fluconazole prophylaxis against fungal colonization and infection in preterm infants", N Engl J Med, 345, pp.1660~1666 (2001)
21. Kaufman D, "Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight", J Pediatr, 147, pp.172~179 (2005)
22. Manzoni P, "A multicenter randomized trial of prophylactic fluconazole in preterm neonates", N Engl J Med, 356, pp.2483~2495 (2007)
23. Gutierrez K, "Pharmacology review newer antibiotics: cefepime", Neoreviews, 5, pp.382~386 (2004)
24. Young TE, "Aminoglycoside therapy in neonates with particular reference to gentamicin", Neoreviews, 12, pp.243~248 (2002)
25. Garges HP, "Pharmacology review newer antibiotics: imipenem", cilastatin and meropenem, 2003, pp.12, 364~368
26. Deville JG, "Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates", Pediatr Infect Dis J, 22, pp.158~163 (2003)
27. Kocher S, "Linezolid treatment of nosocomial bacterial infection with multiresistant Gram-positive pathogens in preterm infants: a systematic review", Int J Antimicrob Agents, 36, pp.106~110 (2010)
28. Steenbergen JN, "Daptomycin: a lipopeptide antibiotics for the treatment of serious Gram-positive infections", J Antimicrob Chemother, 55, pp.283~288 (2005)
29. Young TE, "A manual of drugs used in neonatal care,24th ed", pp.1~98 (2011), Thomson Reuters
30. Touw DJ, "Therapeutic drug monitoring aminoglycosides in neonates", Clin Pharmacokinet, 48, pp.71~88 (2009)
31. 이진아, "신생아 급성 신부전의 치료", Neonatal medicine, 17(2), pp.168~180 (2010), 대한신생아학회
32. Shin WK, "Pediatric pharmacokinetics", J Korean Soc Hosp Pharm, 12, pp.161~167 (1995)
33. Gilman JT, "Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications", Clin Pharmacokinet, 19, pp.1~10 (1990)
34. Kadambari S, "Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units", J Antimicrob Chemother, 66, pp.2647~2650 (2011)
35. Tang HY, "Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?", Genet Med, 4, pp.336~345 (2002)
36. Patel SJ, "Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance", Pediatr Infec Dis J, 28, pp.1047~1051 (2009)

관련 논문AI추천